Type I

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]

People with Type 1 at Risk for COVID-19 Complications

Researchers continue examining the relationship between diabetes and coronavirus. In a new study looking specifically at type 1 diabetes, they found that about half the people in the study with type 1 and COVID-19 had abnormally high blood sugar, which demonstrates how COVID-19 can complicate blood sugar control. Read more

AI Could Help Manage Type 1 Diabetes

Researchers at Oregon Health & Science University have developed a new method to help people with type 1 diabetes manage their glucose levels. The system uses artificial intelligence and automated monitoring, and generates recommendations that were similar to those from endocrinologists, the researchers say. Read more

Type 1 Diabetes Costs US Patients $2500 a Year, Even with Insurance

A new study found that out-of-pocket costs for Americans who have type 1 diabetes average $2,500 a year. And 8% of patients pay more than $5,000 out-of-pocket, perhaps due to high-deductible health insurance plans or significant medical needs. Insulin accounts for only 18% of this spending, with insulin pumps, syringes, CGMs and other supplies making […]

High Intensity Interval Training Shows Health Benefits for Type 1

Previous studies have shown that high intensity interval training (HIIT) improves vascular function without causing hypoglycemia, which can often be associated with moderate-intensity exercise. These studies were performed under strict supervision; a recent study sought to examine whether the benefits of HIIT would be seen in people with type 1 exercising at home. Read more

Statins and Type 1

A recent study conducted a risk assessment of cardiovascular disease, studying adherence to lipid-lowering medications in people with type 1 diabetes, to better understand how decreasing lipids could impact patients with type 1. Read more

How Does COVID-19 Affect Those with Type 1?

The Centers for Disease Control and Prevention (CDC) has noted that people with diabetes are at increased risk for severe complications if they contract COVID-19, but the agency has not addressed whether people with type 1 face different risk than those with type 2 diabetes. Now researchers are launching a study to look specifically at […]

Reversing Diabetes with Gene Editing

Scientists at Washington University announced they have developed a way to use gene editing system CRISPR-Cas9 to edit a mutation certain stem cells and then turn them into beta cells that produce insulin. When transplanted into mice, the cells reversed preexisting diabetes. Read more

Dapagliflozin for Type 1?

The European Medicines Agency has extended the indication for dapagliflozin for patients with type 1 diabetes, as well as type 2.  Still, these treatments have not been FDA approved for type 1 patients in the US. Two trials were conducted to assess how dapagliflozin performed when it was added to the medication regimen for a patient […]

Would Mass Screening Benefit Children at High Diabetes Risk?

There is currently no way to prevent type 1 diabetes, but screening trials suggest finding high-risk children early can reduce severe illness at diagnosis. Identifying children likely to develop diabetes could also speed the testing of preventive therapies. Read more

Type 1 Diabetes May be Two Distinct Conditions

New research has found that children diagnosed with type 1 diabetes under the age of seven have a different type (specifically “endotype”) of the condition compared to patients with diabetes who have been diagnosed at age thirteen or above. These findings could spur further research into whether dormant insulin-producing cells can be reactivated.  Read more

Diabetes and COVID-19

People with chronic health conditions, including diabetes, are at greater risk of developing serious complications if they contract the novel coronavirus, COVID-19. The American Diabetes Association (ADA) has guidance on what the coronavirus means for people with diabetes, and some tips on how best to protect yourself during this pandemic. Read more

Qualifying for Social Security Disability with Diabetes

Type 1 diabetes doesn’t always qualify for disability benefits, but some people are able to receive monthly disability benefits from the Social Security Administration (SSA). Your benefits can be used on hospital bills and medical treatments, rent, utility bills, food expenses, and any other daily living needs.  Read more

Both Type 1 and Type 2 Diabetes on the Rise in Young People

A new Centers for Disease Control and Prevention study found an alarming increase of both type 1 and type 2 diabetes in children and teenagers. The study found type 2 cases increased by seven percent in the last 10 years, with the number of type 1 cases also rising. Read more

Regular Thyroid Tests with Any Type of Diabetes?

The American Diabetes Association (ADA) already recommends thyroid testing for people with type 1 diabetes, but a new analysis suggests that thyroid dysfunction is common in people with diabetes regardless of type, and that biochemical thyroid screening should be routine for people with type 2 as well as type 1. Read more

Value of MODY Testing in Type 1 Patients

People with maturity-onset diabetes of the young (MODY) can often have reasonable long-term glycemic control without insulin, but MODY diagnosis is difficult because no single commonly used clinical criteria separates it from type 1 or 2 diabetes. With the difference in therapy between type 1 diabetes and MODY, a correct diagnosis of MODY leads to […]

The Diabetes-Cancer Link

The link between cancer and diabetes is not entirely understood, but biological mechanisms linking diabetes and cancer include hyperglycemia, hyperinsulinemia, oxidative stress, dysregulations of sex hormones, and chronic inflammation. Although there is a known risk for cancer for people with diabetes, routine checks are still absent, and the potential of early detection and treatment of […]

FDA Approval for First Automated Insulin Dosing Controller

The Tandem t:slim X2 insulin pump will not only discontinue the delivery of insulin if blood sugars detected by a CGM record low blood sugars, but will also calculate the amount of insulin needed and inject that insulin when needed for elevated blood sugars. Read more

Diabulemia in Type 1

Diabulemia is a term used to describe an eating disorder in diabetes patients in which the patient deliberately restricts insulin in order to lose weight; medical professionals may also use the term ED-DMT1, Eating Disorder-Diabetes Mellitus Type 1, which is used to refer to any type of eating disorder in combination with with type 1 […]

Many with Type 1 Diabetes Turn to Black Market for Supplies

An online survey found that many patients with diabetes in the United States trade or buy diabetes drugs and supplies through an “underground exchange,” or black market, due to trouble paying deductibles or copays. Survey respondents included adults with type 1 diabetes and parents of children with type 1. Read more